Menu
- Office Hour : 08:00am - 6:00pm
At Cohance Lifesciences, we deliver comprehensive solutions in nucleic acid chemistry enabling the advancement of cutting-edge therapeutics from early-stage research to commercial supply. Our capabilities span custom nucleic acid synthesis, including Phosphoramidites and Nucleoside Triphosphates, along with robust process development, scale-up, and GMP-grade manufacturing. We cater to therapeutic companies developing commercial drugs based on ASOs, siRNAs, aptamers, and other emerging nucleic acid modalities.
With Sapala Organics as our strategic partner, we bring differentiated strength in complex nucleoside chemistry and custom synthesis — reinforcing our ability to deliver precision and performance at every stage. Together, we offer a seamlessly integrated platform for nucleic acid building blocks and therapeutic development.
Backed by scientific depth, advanced infrastructure, and global regulatory alignment, Cohance is a trusted partner to biotech and pharmaceutical innovators worldwide. Our dedicated nucleic acid platforms are designed for agility, scalability, and quality…ensuring you move confidently across the development lifecycle.